Rainbow Childrens Medicare Limited (IN:RAINBOW)
:RAINBOW
Top Page
Rainbow Childrens Medicare Limited
(RAINBOW)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹1,239.00
▼(-8.14% Downside)
Action:ReiteratedDate:10/22/25
Rainbow Childrens Medicare Limited's overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth and solid cash flow generation. However, the technical analysis indicates a bearish trend, and the high P/E ratio suggests potential overvaluation, which negatively impacts the overall score.
Positive Factors
Strong historical revenue growth
The company’s multi-year revenue jump shows durable demand for its services and expanding scale. Growing top-line supports continued investment in capacity, specialist staff and technology, and underpins longer-term margin and profit expansion if growth execution is maintained.
Negative Factors
Rising total liabilities
An upward trend in total liabilities can erode financial flexibility even if current leverage is manageable. Over a 2-6 month horizon rising obligations may increase interest and refinancing risk, constrain investment capacity and pressure credit metrics if cash generation weakens.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong historical revenue growth
The company’s multi-year revenue jump shows durable demand for its services and expanding scale. Growing top-line supports continued investment in capacity, specialist staff and technology, and underpins longer-term margin and profit expansion if growth execution is maintained.
Read all positive factors
Rainbow Childrens Medicare Limited (RAINBOW) vs. iShares MSCI India ETF (INDA)
Market Cap
₹112.34B
Dividend Yield0.22%
Average Volume (3M)8.91K
Price to Earnings (P/E)46.2
Beta (1Y)0.42
Revenue Growth9.91%
EPS Growth9.57%
CountryIN
Employees3,940
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)7.10
Shares Outstanding101,559,160
10 Day Avg. Volume4,219
30 Day Avg. Volume8,914
Financial Highlights & Ratios
PEG Ratio4.75
Price to Book (P/B)9.54
Price to Sales (P/S)9.24
P/FCF Ratio56.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.68
Revenue Forecast (FY)₹16.72B
Rainbow Childrens Medicare Limited Business Overview & Revenue Model
Company Description
Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver disea...
How the Company Makes Money
RAINBOW primarily makes money by providing healthcare services to patients through its hospitals and clinics. Key revenue streams typically include (1) in-patient services (room/bed charges, nursing, ICU/NICU care, procedure and operating theatre ...
Rainbow Childrens Medicare Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.66B | 15.16B | 12.97B | 11.74B | 9.74B | 6.50B |
| Gross Profit | 8.41B | 10.82B | 9.31B | 8.44B | 6.44B | 4.24B |
| EBITDA | 4.99B | 4.37B | 3.90B | 3.65B | 2.73B | 1.35B |
| Net Income | 2.54B | 2.43B | 2.17B | 2.11B | 1.38B | 400.18M |
Balance Sheet | ||||||
| Total Assets | 25.87B | 23.77B | 21.70B | 17.76B | 14.24B | 10.81B |
| Cash, Cash Equivalents and Short-Term Investments | 4.42B | 6.94B | 5.02B | 3.81B | 2.03B | 1.03B |
| Total Debt | 8.16B | 7.64B | 7.65B | 5.70B | 5.79B | 5.18B |
| Total Liabilities | 10.54B | 9.02B | 9.05B | 7.06B | 6.89B | 6.33B |
| Stockholders Equity | 15.18B | 14.68B | 12.59B | 10.60B | 6.03B | 4.46B |
Cash Flow | ||||||
| Free Cash Flow | -946.85M | 2.50B | -321.75M | 1.86B | 1.62B | 666.11M |
| Operating Cash Flow | 2.08B | 3.96B | 3.21B | 3.27B | 2.24B | 1.43B |
| Investing Cash Flow | -1.25B | -2.68B | -2.26B | -4.65B | -1.75B | -828.80M |
| Financing Cash Flow | -762.19M | -1.18B | -1.02B | 1.43B | -440.62M | -608.73M |
Rainbow Childrens Medicare Limited Technical Analysis
Negative
1348.80
Price Trends
1186.92
Negative
1266.26
Negative
1365.88
Negative
Market Momentum
-24.85
Positive
34.94
Neutral
16.88
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RAINBOW, the sentiment is Negative. The current price of 1348.8 is above the 20-day moving average (MA) of 1170.32, above the 50-day MA of 1186.92, and below the 200-day MA of 1365.88, indicating a bearish trend. The MACD of -24.85 indicates Positive momentum. The RSI at 34.94 is Neutral, neither overbought nor oversold. The STOCH value of 16.88 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:RAINBOW.
Rainbow Childrens Medicare Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ₹29.17B | 43.39 | ― | 0.85% | ― | ― | |
67 Neutral | ₹77.77B | -247.47 | ― | ― | 17.58% | -38.20% | |
67 Neutral | ₹17.84B | 38.21 | ― | 0.16% | 17.05% | 56.84% | |
66 Neutral | ₹112.34B | 46.21 | ― | 0.22% | 9.91% | 9.57% | |
62 Neutral | ₹129.69B | 76.03 | ― | 0.46% | 10.09% | -19.40% | |
58 Neutral | ₹18.61B | 38.37 | ― | 0.38% | 11.51% | 21.56% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:RAINBOW
Rainbow Childrens Medicare Limited
1,147.25
-192.58
-14.37%
IN:HCG
HealthCare Global Enterprises Ltd.
526.50
0.75
0.14%
IN:JUBLPHARMA
Jubilant Pharmova Limited
859.10
-7.74
-0.89%
IN:KRSNAA
Krsnaa Diagnostics Limited
564.90
-225.16
-28.50%
IN:RPGLIFE
RPG Life Sciences Limited
1,763.95
-480.26
-21.40%
IN:VIMTALABS
Vimta Labs Limited
417.55
-101.54
-19.56%
Rainbow Childrens Medicare Limited Corporate Events
Rainbow Children’s Medicare Expands Bengaluru Footprint with New 90-Bed Hospital in Electronic City
Jan 28, 2026
Rainbow Children’s Medicare Limited has inaugurated a new 90-bed spoke hospital in Electronic City, Bengaluru, increasing its total capacity to approximately 2,375 beds across India. The ₹55 crore facility, funded through internal accr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.